AKYNZEO 300 mg/0.5 mg, capsules capsule
Active ingredients: (3aS)-palonosetron hydrochloride, Netupitant, (3aS)-palonosetron
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsulecapsuleorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AKYNZEO 300 mg/0,5 mg, gélules
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium de 1 gélule(s)
- Marketing authorisation holder
- HELSINN BIREX PHARMACEUTICALS
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Prévention chez l'adulte des fortes nausées et vomissements entraînés par certaines chimiothérapies utilisant du cisplatine. ; JOURNAL OFFICIEL ; 07/11/17
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Nov 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67693946CIP73003862CIP133400930038628Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NÉTUPITANTgélule | 300 mg · une gélule | SA |
| CHLORHYDRATE DE PALONOSÉTRONgélule | 0,56 mg · une gélule | SA |
| PALONOSÉTRONgélule | 0,5 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.